Treatment may involve oral high-dose B12 tablets or intramuscular hydroxocobalamin injections , depending on the underlying cause (see the following section for dosing detail)
Standard blood workincluding complete blood counts, comprehensive metabolic panels, lipid profiles, or HbA1c measurementsassesses various health markers and metabolic parameters but does not identify or quantify GLP-1 medications in the bloodstream
Importantly, there is an absence of data demonstrating development of chronic pancreatitis in humans treated with GLP-1RAs to support this connection
A doctor may sometimes recommend combining oral support, topical therapy, and selected in-clinic procedures depending on clinical findings and patient goals
Patent pressure is reshaping strategy Since 2005, nearly 10,000 GLP-1R related patents have been filed, but the rate of filings and grants is trending downward